Form 4: UnitedHealth Director Adds 43 Shares via Dividends

UnitedHealth Group Director John H. Noseworthy acquired 43 shares of common stock on December 16, 2025, through dividend equivalents on vested deferred stock units.

Summary

• John H. Noseworthy, a Director of UnitedHealth Group Inc. (UNH), acquired 43 shares of common stock.
• The transaction occurred on December 16, 2025.
• These shares represent dividend equivalents paid on vested deferred stock units.
• The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units.
• The acquisition price was $0 per share, as it represents a distribution of dividends.
• Following this transaction, John H. Noseworthy beneficially owns 6,736 shares of UnitedHealth Group common stock directly.

Sentiment

Score: 6

Explanation: Slightly positive as an insider increased their holdings, albeit through a routine dividend equivalent, indicating continued alignment with the company.

Positives

• Director John H. Noseworthy increased his direct beneficial ownership of UnitedHealth Group common stock by 43 shares.
• The acquisition of shares through dividend equivalents indicates a routine, non-sale transaction, often viewed as a positive sign of continued insider alignment with shareholder interests.

Negatives

• No negative information is disclosed in this routine insider transaction report.

Risks

• No specific risks are mentioned in this Form 4 filing, which primarily reports a change in beneficial ownership.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction filing (Form 4) and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual director's equity holdings rather than company-wide strategic developments.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, employees, customers, suppliers, or creditors, as it is a routine change in an individual director's beneficial ownership through dividend equivalents.

Key Dates

Keywords

UnitedHealth Group, UNH, Form 4, Insider Transaction, Stock Acquisition, Director, Dividend Equivalents, Deferred Stock Units, Beneficial Ownership